KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amgen (AMGN) Net Income towards Common Stockholders (2016 - 2026)

Amgen has reported Net Income towards Common Stockholders over the past 18 years, most recently at $1.8 billion for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders rose 5.14% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $7.8 billion, up 31.47%, while the annual FY2025 figure was $7.7 billion, 88.53% up from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 was $1.8 billion at Amgen, up from $1.3 billion in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $3.2 billion in Q3 2025 and troughed at -$113.0 million in Q1 2024.
  • A 5-year average of $1.6 billion and a median of $1.5 billion in 2022 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 103.98% in 2024 and later surged 1630.97% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at $1.6 billion in 2022, then plummeted by 52.54% to $767.0 million in 2023, then fell by 18.25% to $627.0 million in 2024, then surged by 112.6% to $1.3 billion in 2025, then skyrocketed by 36.46% to $1.8 billion in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for AMGN at $1.8 billion in Q1 2026, $1.3 billion in Q4 2025, and $3.2 billion in Q3 2025.